Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.55 |
| ▸ | GNPAT | O15228 | 1/20 | 0.51 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.50 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.50 |
| ▸ | GLP1R | P43220 | 8/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | FNTA | P49354 | 1/20 | 0.48 |
| ▸ | FNTB | P49356 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21172323 | 0.88 | GLP1R (0.48) | NOD1FOLH1SLC6A5GLP1RFNTA | |
| SCHEMBL24805414 | 0.87 | NOD1 (0.53) | NOD1GNPATFOLH1SLC6A5GLP1R | |
| SCHEMBL21170437 | 0.87 | NOD1 (0.53) | NOD1GNPATFOLH1GLP1REPHX2 | |
| SCHEMBL21126875 | 0.86 | NOD1 (0.52) | NOD1GNPATFOLH1GLP1REPHX2 | |
| SCHEMBL23365799 | 0.86 | NOD1 (0.58) | NOD1FOLH1SLC6A5GLP1REPHX2 | |
| SCHEMBL14238761 | 0.86 | NOD1 (0.52) | NOD1GNPATFOLH1GLP1REPHX2 | |
| SCHEMBL23129208 | 0.86 | NOD1 (0.52) | NOD1GNPATFOLH1GLP1REPHX2 | |
| SCHEMBL21172243 | 0.86 | NOD1 (0.58) | NOD1FOLH1SLC6A5GLP1REPHX2 | |
| SCHEMBL12518531 | 0.86 | NOD1 (0.52) | NOD1GNPATFOLH1GLP1REPHX2 | |
| SCHEMBL20414814 | 0.86 | NOD1 (0.58) | NOD1FOLH1SLC6A5GLP1REPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2981282-B1 | GROWTH HORMONE COMPOUND FORMULATION | NOVO NORDISK HEALTHCARE AG (CH) | 2020-11-04 | — | — | EP | disclosed |
| EP-2525834-B1 | GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY | NOVO NORDISK HEALTHCARE AG (CH) | 2019-07-17 | — | — | EP | disclosed |